Cure MSA

Country specific patient information

Baronica KB, Ivkic G, Ozretic D, Milicevic G. Differential diagnostic relevance of high resolution magnetic resonance in patients with possible multiple system atrophy (MSA) - A case report. Coll Antropol 2011;35 Suppl 1:287-292.

 

Brooks JA, Houlden H, Melchers A, Islam AJ, Ding J, Li A, Paudel R, Revesz T, Holton JL, Wood N, Lees A, Singleton AB, Scholz SW. Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiol Aging 2011;32:548 e545-547.

 

Colosimo C. Nonmotor presentations of multiple system atrophy. Nat Rev Neurol 2011;7:295-298.

 

De Cock VC, Debs R, Oudiette D, Leu S, Radji F, Tiberge M, Yu H, Bayard S, Roze E, Vidailhet M, Dauvilliers Y, Rascol O, Arnulf I. The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Brain 2011;134:856-862.

 

Dongmei H, Jing L, Mei X, Ling Z, Hongmin Y, Zhidong W, Li D, Zikuan G, Hengxiang W. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy 2011;13:913-917.

 

d'Ouince VM, Bories-Desjardins F, Souchon S, Miric D, Hallet-Lezy AM. A report of atypical autopsy-confirmed multiple-system atrophy. J Am Geriatr Soc 2011;59:1354-1355.

 

Fernagut PO, Tison F. Animal models of multiple system atrophy. Neuroscience 2012;211:77-82.

 

Fernagut PO, Vital A, Canron MH, Tison F, Meissner WG. Ambiguous mechanisms of dysphagia in multiple system atrophy. Brain 2012;135:e205; author reply e206.

 

Fischer MD, Synofzik M, Heidlauf R, Schicks J, Srulijes K, Kernstock C, Berg D, Schols L, Schiefer U. Retinal nerve fiber layer loss in multiple system atrophy. Mov Disord 2011;26:914-916.

 

Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM. Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiol Dis 2012;45:188-195.

 

Fujimori J, Tatewaki Y, Shimizu H, Kimura I, Hisanaga K. [Degeneration of ponto-cerebellar tract visualized by diffusion tensor imaging in multiple system atrophy]. Rinsho Shinkeigaku 2011;51:271-274.

 

Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S, Low PA, Lee VM, Trojanowski JQ. TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathol Appl Neurobiol 2011;37:358-365.

 

Glass PG, Lees AJ, Mathias C, Mason L, Best C, Williams DR, Katzenschlager R, Silveira-Moriyama L. Olfaction in pathologically proven patients with multiple system atrophy. Mov Disord 2012;27:327-328.

 

Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro alpha-synuclein fibril formation. Neurosci Lett 2011;491:48-52.

 

Hong HJ, Song SK, Lee PH, Sohn YH, Lee JE. Cognitive impairments in multiple system atrophy of the cerebellar type. J Mov Disord 2011;4:41-45.

 

Honjo Y, Ito H, Horibe T, Takahashi R, Kawakami K. Protein disulfide isomerase immunopositive glial cytoplasmic inclusions in patients with multiple system atrophy. Int J Neurosci 2011;121:543-550.

 

Ichikawa Y, Goto J, Nakahara Y, Mitsui J, Tsuji S. [Therapeutic trial design issues for future disease-modifying therapy of multiple system atrophy]. Rinsho Shinkeigaku 2011;51:910-913.

 

Kakeda S, Korogi Y, Yoneda T, Nishimura J, Sato T, Hiai Y, Ohnari N, Okada K, Hayashi H, Matsusue E, Uozumi T, Tsuji S. A novel tract imaging technique of the brainstem using phase difference enhanced imaging: normal anatomy and initial experience in multiple system atrophy. Eur Radiol 2011;21:2202-2210.

 

Kasahara S, Miki Y, Kanagaki M, Kondo T, Yamamoto A, Morimoto E, Okada T, Ito H, Takahashi R, Togashi K. "Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging. Eur J Radiol 2012;81:2848-2852.

 

Kikuchi A, Baba T, Hasegawa T, Sugeno N, Konno M, Takeda A. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Parkinsonism Relat Disord 2011;17:698-700.

 

Kim HJ, Jeon BS, Lee JY. Serum urate levels are not associated with survival in multiple system atrophy. Parkinsonism Relat Disord 2011;17:400-401.

 

Kim HJ, Jeon BS, Lee JY, Yun JY. Survival of Korean patients with multiple system atrophy. Mov Disord 2011;26:909-912.

 

Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, Okazaki T. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT. J Neuroimaging 2011;21:132-137.

 

Kohli J, Brandt N. Multiple-system atrophy and medications: how to minimize the risk of falling. Consult Pharm 2011;26:190-196.

 

Kollensperger M, Krismer F, Pallua A, Stefanova N, Poewe W, Wenning GK. Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy. Mov Disord 2011;26:507-515.

 

Lee JE, Song SK, Sohn YH, Lee PH. Uric acid as a potential disease modifier in patients with multiple system atrophy. Mov Disord 2011;26:1533-1536.

 

Lee JH, Baik SK. Putaminal hypointensity in the parkinsonian variant of multiple system atrophy: simple visual assessment using susceptibility-weighted imaging. J Mov Disord 2011;4:60-63.

 

Louter M, Pelleboer RH, van den Broek GB, Post B, Pevernagie DA, Overeem S. [Nocturnal stridor in multiple system atrophy]. Ned Tijdschr Geneeskd 2011;155:A3621.

 

Madan A, Schiess MC. Intrathecal baclofen therapy slows progressive disability in multiple system atrophy. Neuromodulation 2011;14:176-177; discussion 178.

 

Maeda R, Yamashita S, Inomata S, Tanaka M, Mizutani T. [Anesthetic management of a patient with multiple system atrophy undergoing adrenal gland tumor surgery]. Masui 2011;60:1173-1175.

 

Makino T, Ito S, Kuwabara S. Involvement of pontine transverse and longitudinal fibers in multiple system atrophy: a tractography-based study. J Neurol Sci 2011;303:61-66.

 

Martinez del Valle Torres MD, Ramos Moreno E, Amrani Raissouni T, Ortega Lozano SJ, Sanz Viedma S, Jimenez-Hoyuela JM. [Functional assessment of nigro-striatal pathway with FP-CIT in patients with multiple system atrophy subtype C]. Med Clin (Barc) 2011;137:440-443.

 

Masui K, Nakata Y, Fujii N, Iwaki T. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology 2012;32:69-76.

 

McCrone P, Payan CA, Knapp M, Ludolph A, Agid Y, Leigh PN, Bensimon G, Group NS. The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom. PLoS One 2011;6:e24369.

 

Mehta AR, Fox SH, Tarnopolsky M, Yoon G. Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype. Mov Disord 2011;26:753-755.

 

Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, Salsone M, Morelli M, Lanza PL, Quattrone A. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord 2011;17:172-176.

 

Moreno-Lopez C, Santamaria J, Salamero M, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Overeem S, Bloem B, Aarden W, Canesi M, Antonini A, Duerr S, Wenning GK, Poewe W, Rubino A, Meco G, Schneider SA, Bhatia KP, Djaldetti R, Coelho M, Sampaio C, Cochen V, Hellriegel H, Deuschl G, Colosimo C, Marsili L, Gasser T, Tolosa E. Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol 2011;68:223-230.

 

Munoz E, Iranzo A, Rauek S, Lomena F, Gallego J, Ros D, Santamaria J, Tolosa E. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C). J Neurol 2011;258:2248-2253.

 

Nagaishi M, Yokoo H, Nakazato Y. Tau-positive glial cytoplasmic granules in multiple system atrophy. Neuropathology 2011;31:299-305.

 

Nakayama K, Suzuki Y, Yazawa I. Binding of neuronal alpha-synuclein to beta-III tubulin and accumulation in a model of multiple system atrophy. Biochem Biophys Res Commun 2012;417:1170-1175.

 

Nomura T, Inoue Y, Hogl B, Uemura Y, Yasui K, Sasai T, Namba K, Nakashima K. Comparison of the clinical features of rapid eye movement sleep behavior disorder in patients with Parkinson's disease and multiple system atrophy. Psychiatry Clin Neurosci 2011;65:264-271.

 

Oz G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum 2011;10:208-217.

 

Ozawa T, Saji E, Yajima R, Onodera O, Nishizawa M. Reduced bowel sounds in Parkinson's disease and multiple system atrophy patients. Clin Auton Res 2011;21:181-184.

 

Park HJ, Bang G, Lee BR, Kim HO, Lee PH. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism. Cell Transplant 2011;20:827-835.

 

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G, Group NS. Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale. PLoS One 2011;6:e22293.

 

Pellecchia MT, Barone P, Vicidomini C, Mollica C, Salvatore E, Ianniciello M, Liuzzi R, Longo K, Picillo M, De Michele G, Filla A, Brunetti A, Salvatore M, Pappata S. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord 2011;26:1303-1309.

 

Perju-Dumbrava LD, Kovacs GG, Pirker S, Jellinger K, Hoffmann M, Asenbaum S, Pirker W. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy. Mov Disord 2012;27:65-71.

 

Pountney DL, Dickson TC, Power JH, Vickers JC, West AJ, Gai WP. Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurotox Res 2011;19:115-122.

 

Ragothaman M, Swaminath PV, Sarangmath N, Koshy S, Adhyam M, Subbakrishna DK, Mathias CJ, Muthane UB. Role of dysautonomic symptoms in distinguishing Parkinson's disease (PD) from multiple system atrophy (MSA-P) within a year of developing motor symptoms. J Assoc Physicians India 2011;59:95-98.

 

Rice CM, McGuone D, Kurian KM, Love S, Renowden SA, Giffin NJ. Autopsy-confirmed, co-existent CADASIL and multiple system atrophy. Parkinsonism Relat Disord 2011;17:390-392.

 

Rolland Y, Verin M, Payan CA, Duchesne S, Kraft E, Hauser TK, Jarosz J, Deasy N, Defevbre L, Delmaire C, Dormont D, Ludolph AC, Bensimon G, Leigh PN, Group NS. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry 2011;82:1025-1032.

 

Sakurai K, Yamawaki T, Okita K, Kato D, Matsukawa N, Kawaguchi T, Kobayashi S, Nagai K, Muto M, Hosono A, Shibamoto Y. Utility of the fluid-attenuated inversion recovery sequence in detecting a hyperintense putaminal rim in multiple system atrophy-parkinsonism: a preliminary study. Eur Neurol 2011;66:42-46.

 

Samukawa M, Hirano M, Sakamoto H, Kitada M, Kusunoki S, Nakamura Y. Risks of inappropriate secretion of antidiuretic hormone in multiple system atrophy. Mov Disord 2011;26:2572-2573.

 

Sasaki H, Emi M, Iijima H, Ito N, Sato H, Yabe I, Kato T, Utsumi J, Matsubara K. Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy. Mol Brain 2011;4:24.

 

Schmidt KI, Spiegel J, Reith W. [Clinical and imaging diagnostics of Parkinson's disease and multiple system atrophy]. Radiologe 2011;51:273-277.

 

Seok HY, Eun MY, Park KW, Yu SW. FDG-PET and MRI features in multiple system atrophy. Acta Neurol Belg 2011;111:76-77.

 

Serrao M, Di Fabio R, Bartolo M, Perrotta A, Tassorelli C, Coppola G, Davassi C, Padua L, Sandrini G, Pierelli F. The contribution of trigemino-cervical reflexes in distinguishing progressive supranuclear palsy from multiple system atrophy. Clin Neurophysiol 2011;122:1812-1815.

 

Shimohata T, Tomita M, Nakayama H, Aizawa N, Ozawa T, Nishizawa M. Floppy epiglottis as a contraindication of CPAP in patients with multiple system atrophy. Neurology 2011;76:1841-1842.

 

Song SK, Lee SK, Lee JJ, Lee JE, Choi HS, Sohn YH, Lee PH. Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy. Neurobiol Aging 2011;32:2183-2189.

 

Stefanova N, Georgievska B, Eriksson H, Poewe W, Wenning GK. Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox Res 2012;21:393-404.

 

Stemberger S, Jamnig A, Stefanova N, Lepperdinger G, Reindl M, Wenning GK. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. PLoS One 2011;6:e19808.

 

Stemberger S, Scholz SW, Singleton AB, Wenning GK. Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging 2011;32:1924 e1925-1914.

 

Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy. BMC Neurol 2011;11:157.

 

Takado Y, Igarashi H, Terajima K, Shimohata T, Ozawa T, Okamoto K, Nishizawa M, Nakada T. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study. Mov Disord 2011;26:1297-1302.

 

Treglia G, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. Clin Neurol Neurosurg 2011;113:823-829.

 

Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 2011;34:581-590.

 

Ullman M, Vedam-Mai V, Resnick AS, Yachnis AT, McFarland NR, Merritt S, Zeilman P, Foote KD, Okun MS. Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy. Parkinsonism Relat Disord 2012;18:86-88.

 

Umoto M, Miwa H, Ando R, Kajimoto Y, Kondo T. White matter hyperintensities in patients with multiple system atrophy. Parkinsonism Relat Disord 2012;18:17-20.

 

Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, Lyons KE, Uitti RJ, Wszolek ZK, Dickson DW, Farrer MJ, Ross OA. MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology 2011;76:670-672.

 

Wakabayashi K. [Glial cytoplasmic inclusions in multiple system atrophy]. Nihon Rinsho 2011;69 Suppl 8:180-184.

 

Wang PS, Wu HM, Lin CP, Soong BW. Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology 2011;53:471-481.

 

Wang Y, Butros SR, Shuai X, Dai Y, Chen C, Liu M, Haacke EM, Hu J, Xu H. Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012;33:266-273.

 

Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol 2011;178:1509-1516.

 

Wang ZF, Wang Q, Wu WP. A case of multiple system atrophy: onset with the cold hands sign. Chin Med J (Engl) 2011;124:1719.

 

Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Hoglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R. Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 2011;8:438-446.

 

Winter Y, Stamelou M, Cabanel N, Sixel-Doring F, Eggert K, Hoglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE. Cost-of-illness in multiple system atrophy and progressive supranuclear palsy. J Neurol 2011;258:1827-1834.

 

Wujtewicz MA, Chwojnicki K, Owczuk R, Wujtewicz M. Laryngeal dystonia in the course of multiple system atrophy: a cause of postoperative respiratory insufficiency. Neurol Sci 2012;33:681-683.

 

Yamada M. [Initial cellular target in multiple system atrophy: glial cell]. Rinsho Shinkeigaku 2011;51:843.

 

Yoon HH, Lee CS, Hong SH, Min J, Kim YH, Hwang O, Jeon SR. Evaluation of a multiple system atrophy model in rats using multitracer microPET. Acta Neurochir (Wien) 2012;154:935-940.

 

Yoshida M. [Multiple system atrophy - synuclein and neuronal degeneration]. Rinsho Shinkeigaku 2011;51:838-842.

 

You H, Wang J, Wang H, Zang YF, Zheng FL, Meng CL, Feng F. Altered regional homogeneity in motor cortices in patients with multiple system atrophy. Neurosci Lett 2011;502:18-23.

 

Zhu L, Cairns NJ, Tabbal SD, Racette BA. Pregnancy in multiple system atrophy: a case report. J Med Case Rep 2011;5:599.